Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

260 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Primary membranous nephropathy in the Italian region of Emilia Romagna: results of a multicenter study with extended follow-up.
Albertazzi V, Fontana F, Giberti S, Aiello V, Battistoni S, Catapano F, Graziani R, Cimino S, Scichilone L, Forcellini S, De Fabritiis M, Sara S, Delsante M, Fiaccadori E, Mosconi G, Storari A, Mandreoli M, Bonucchi D, Buscaroli A, Mancini E, Rigotti A, La Manna G, Gregorini M, Donati G, Cappelli G, Scarpioni R; Gruppo di Studio della Glomerulonefrite Membranosa in Emilia Romagna. Albertazzi V, et al. Among authors: fiaccadori e. J Nephrol. 2024 Mar;37(2):471-482. doi: 10.1007/s40620-023-01803-9. Epub 2023 Nov 13. J Nephrol. 2024. PMID: 37957455
Borderline rejection: To treat or not to treat?
Palmisano A, D'Angelo M, Gandolfini I, Delsante M, Rossi GM, Gentile M, Fiaccadori E, Cravedi P, Maggiore U. Palmisano A, et al. Among authors: fiaccadori e. Transpl Immunol. 2024 Apr 18;84:102047. doi: 10.1016/j.trim.2024.102047. Online ahead of print. Transpl Immunol. 2024. PMID: 38641147
CXCL9 and CXCL10 as biomarkers of kidney graft inflammation across multiple conditions.
Gandolfini I, Mordà B, Martinelli E, Delsante M, Rossi G, Gentile M, Alibrandi S, Salvetti D, Fiaccadori E, Palmisano A, Cravedi P, Maggiore U. Gandolfini I, et al. Among authors: fiaccadori e. Clin Transplant. 2024 May;38(5):e15324. doi: 10.1111/ctr.15324. Clin Transplant. 2024. PMID: 38678588 No abstract available.
Immune abnormalities in IgA nephropathy.
Gentile M, Sanchez-Russo L, Riella LV, Verlato A, Manrique J, Granata S, Fiaccadori E, Pesce F, Zaza G, Cravedi P. Gentile M, et al. Among authors: fiaccadori e. Clin Kidney J. 2023 Feb 8;16(7):1059-1070. doi: 10.1093/ckj/sfad025. eCollection 2023 Jul. Clin Kidney J. 2023. PMID: 37398689 Free PMC article. Review.
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis.
Rossing P, Anker SD, Filippatos G, Pitt B, Ruilope LM, Birkenfeld AL, McGill JB, Rosas SE, Joseph A, Gebel M, Roberts L, Scheerer MF, Bakris GL, Agarwal R; FIDELIO-DKD and FIGARO-DKD Investigators. Rossing P, et al. Diabetes Care. 2022 Dec 1;45(12):2991-2998. doi: 10.2337/dc22-0294. Diabetes Care. 2022. PMID: 35972218 Free PMC article. Clinical Trial.
Use of drug-coated balloons in the percutaneous treatment of arteriovenous fistula stenosis has a time-dependent effect: a retrospective analysis from one dialysis center.
Morganti C, Di Motta T, Andreone A, Bedogni S, Alibrandi S, Benigno G, Paladini I, Epifani E, Fiaccadori E, Maggiore U. Morganti C, et al. Among authors: fiaccadori e. J Nephrol. 2024 May 29. doi: 10.1007/s40620-024-01975-y. Online ahead of print. J Nephrol. 2024. PMID: 38809362 No abstract available.
260 results